Resources Contact Us Home Browse by: INVENTOR PATENT HOLDER PATENT NUMBER DATE     Inventor: Posanski; Ulrich Address: Freiburg, DE No. of patents: 19 Patents: Patent Number Title Of Patent Date Issued 7511014 Cyclosporin galenic forms March 31, 2009 Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10. 7235248 Pharmaceutical compositions comprising cyclosporins June 26, 2007 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2-Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weigh 7081445 Cyclosporin galenic forms July 25, 2006 Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10. 6844459 Pharmaceutical Composition January 18, 2005 Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri 6503883 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis January 7, 2003 The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p 6468968 Cyclosporin galenic forms October 22, 2002 Pharmaceutical compositions comprising a cyclosporin as active ingredient, a fatty acid triglyceride, a glycerol fatty acid partial ester or propylene glycol or sorbitol complete or partial ester, preferably, and a tenside having an HLB of at least 10. 6262022 Pharmaceutical compositions containing cyclosporin as the active agent July 17, 2001 Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-, di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesteri 6258808 Pharmaceutical composition July 10, 2001 Pharmaceutical compositions comprising a cyclosporin in a novel galenic formulations for oral administration. The compositions typically comprise a cyclosporin, 1,2-propylene glycol, a mixed mono-,di- and tri-glyceride and a hydrophilic surfactant. Further a refined glycerol-transesterif 6204243 Pharmaceutical preparations for the targeted treatment of crohn's disease and ulcerative colitis March 20, 2001 The invention relates to a pharmaceutical preparation, which contains an immunosuppressive active agent in dissolved form in a starch capsule, or hard or soft gelatin capsule which has been coated with one or several polymer films. The invention further relates to a process for the p 6024978 Pharmaceutical compositions comprising cyclosporins February 15, 2000 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 -alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular we 6007840 Pharmaceutical compositions comprising cyclosporins December 28, 1999 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 5962017 Pharmaceutical compositions comprising cyclosporins October 5, 1999 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 5962014 Pharmaceutical compositions comprising cyclosporins October 5, 1999 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 5916589 Pharmaceutical compositions comprising cyclosporins June 29, 1999 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 5866159 Pharmaceutical compositions comprising cyclosporins February 2, 1999 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 5756450 Water soluble monoesters as solubilisers for pharmacologically active compounds and pharmaceutic May 26, 1998 A combination of a pharmacologically active compound and a water soluble monoester of a saturated or unsaturated (C.sub.6-18) fatty acid and a polyol, especially a saccharide, particularly as a solid solution of the active compound in the monoester.The solid solution is especially suitab 5741512 Pharmaceutical compositions comprising cyclosporins April 21, 1998 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 5342625 Pharmaceutical compositions comprising cyclosporins August 30, 1994 Pharmaceutical compositions comprising a cyclosporin, e.g. Ciclosporin or [Nva].sup.2 -Ciclosporin, in "microemulsion pre-concentrate" and microemulsion form. The compositions typically comprise (1.1) a C.sub.1-5 alkyl or tetrahydrofurfuryl di- or partial-ether of a low molecular weight 4567161 Liquid active ingredient concentrates for preparation of microemulsions January 28, 1986 Liquid, active substance formulations containing an active substance insoluble or poorly soluble in water, or a mixture, a phospholipid, a special co-emulsifier (glycerinester in which the 1 or 2 OH groups have been esterized with hydrocarbon atoms of 8-16, preferably 8-10, C atoms by       Recently Added Patents Display device Semiconductor device and method of controlling the same Cable having ESD dissipative adhesive electrically connecting leads thereof Organic thin film transistor Antibody and use thereof Wellbore centralizer for tubulars Location-based services platform   Randomly Featured Patents Recording medium having data structure for managing reproduction of at least video data representing multiple reproduction paths and recording and reproducing methods and apparatuses Method and apparatus for producing thermoplastic and products produced therefrom Light source module Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition Package Optical disc and optical disc driving device Water detection unit and system Method and plant utilizing fine coal in a melter gasifier Apparatus for breaking up stacks of paper sheets or the like Front bumper of a vehicle © 2006-2011. PatentGenius.com All Rights Reserved.